The approval was based on a multicenter, randomized, evaluator-blinded, split-hand study (N=89) which showed that treatment with Restylane Lyft resulted in a clinically meaningful improvement in the ...
At ASDS 2025, Galderma unveiled pivotal new data from its range of pioneering Restylane ® hyaluronic acid (HA) injectables, highlighting its versatility in improving the chin profile with Restylane ...
Please provide your email address to receive an email when new articles are posted on . Restylane Eyelight is the first U.S. product formulated with non-animal stabilized hyaluronic acid technology ...
Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that it presented new data from its Injectable Aesthetics portfolio and pipeline at the American Society for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results